These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2354446

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Ferrario A, Kessel D, Gomer CJ.
    Cancer Res; 1992 May 15; 52(10):2890-3. PubMed ID: 1581904
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Chan AL, Juarez M, Allen R, Volz W, Albertson T.
    Photodermatol Photoimmunol Photomed; 2005 Apr 15; 21(2):72-8. PubMed ID: 15752124
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W, Liu Q, Nakagawa H, Sakaki H, Teh B, Matsumiya T, Yoshida H, Imaizumi T, Satoh K, Kimura H.
    Oral Oncol; 2006 Jan 15; 42(1):46-50. PubMed ID: 16266818
    [Abstract] [Full Text] [Related]

  • 5. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM, Wang KK, Zinsmeister AR.
    Cancer; 1998 Jan 15; 82(2):421-7. PubMed ID: 9445202
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
    Taber SW, Fingar VH, Coots CT, Wieman TJ.
    Clin Cancer Res; 1998 Nov 15; 4(11):2741-6. PubMed ID: 9829737
    [Abstract] [Full Text] [Related]

  • 7. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.
    Sheyhedin I, Aizawa K, Araake M, Kumasaka H, Okunaka T, Kato H.
    Photochem Photobiol; 1998 Jul 15; 68(1):110-4. PubMed ID: 9679456
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM.
    Cancer Res; 2001 Aug 01; 61(15):5824-32. PubMed ID: 11479222
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy.
    Nelson JS, Roberts WG, Berns MW.
    Cancer Res; 1987 Sep 01; 47(17):4681-5. PubMed ID: 2957047
    [Abstract] [Full Text] [Related]

  • 13. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response.
    McMahon KS, Wieman TJ, Moore PH, Fingar VH.
    Cancer Res; 1994 Oct 15; 54(20):5374-9. PubMed ID: 7923168
    [Abstract] [Full Text] [Related]

  • 14. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor.
    Webber J, Leeson B, Fromm D, Kessel D.
    J Photochem Photobiol B; 2005 Feb 01; 78(2):135-40. PubMed ID: 15664500
    [Abstract] [Full Text] [Related]

  • 15. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model.
    Kaneko T, Chiba H, Yasuda T, Kusama K.
    Oral Oncol; 2004 Sep 01; 40(8):787-92. PubMed ID: 15288832
    [Abstract] [Full Text] [Related]

  • 16. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
    Peng Q, Moan J, Ma LW, Nesland JM.
    Cancer Res; 1995 Jun 15; 55(12):2620-6. PubMed ID: 7780978
    [Abstract] [Full Text] [Related]

  • 17. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins.
    Gomer CJ, Ryter SW, Ferrario A, Rucker N, Wong S, Fisher AM.
    Cancer Res; 1996 May 15; 56(10):2355-60. PubMed ID: 8625311
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
    Hua Z, Gibson SL, Foster TH, Hilf R.
    Cancer Res; 1995 Apr 15; 55(8):1723-31. PubMed ID: 7712481
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.